221 related articles for article (PubMed ID: 17178392)
1. Simvastatin inhibits NF-kappaB signaling in intestinal epithelial cells and ameliorates acute murine colitis.
Lee JY; Kim JS; Kim JM; Kim N; Jung HC; Song IS
Int Immunopharmacol; 2007 Feb; 7(2):241-8. PubMed ID: 17178392
[TBL] [Abstract][Full Text] [Related]
2. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis.
Cheon JH; Kim JS; Kim JM; Kim N; Jung HC; Song IS
Inflamm Bowel Dis; 2006 Dec; 12(12):1152-61. PubMed ID: 17119390
[TBL] [Abstract][Full Text] [Related]
3. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice.
Lee C; Chun J; Hwang SW; Kang SJ; Im JP; Kim JS
Life Sci; 2014 Jan; 95(1):29-39. PubMed ID: 24239644
[TBL] [Abstract][Full Text] [Related]
4. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
Chun J; Lee C; Hwang SW; Im JP; Kim JS
Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
[TBL] [Abstract][Full Text] [Related]
5. Roxithromycin inhibits nuclear factor kappaB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates experimental colitis in mice.
Choi Y; Koh SJ; Lee HS; Kim JW; Gwan Kim B; Lee KL; Kim JS
Exp Biol Med (Maywood); 2015 Dec; 240(12):1664-71. PubMed ID: 26088864
[TBL] [Abstract][Full Text] [Related]
6. Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis.
Lee C; Lee JW; Seo JY; Hwang SW; Im JP; Kim JS
Life Sci; 2016 Feb; 146():100-8. PubMed ID: 26767626
[TBL] [Abstract][Full Text] [Related]
7. Novel guggulsterone derivative GG-52 inhibits NF-kappaB signaling in intestinal epithelial cells and attenuates acute murine colitis.
Kim JM; Kang HW; Cha MY; Yoo D; Kim N; Kim IK; Ku J; Kim S; Ma SH; Jung HC; Song IS; Kim JS
Lab Invest; 2010 Jul; 90(7):1004-15. PubMed ID: 20195240
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice.
Koh SJ; Kim JM; Kim IK; Kim N; Jung HC; Song IS; Kim JS
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G9-19. PubMed ID: 21436313
[TBL] [Abstract][Full Text] [Related]
9. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.
Cho SJ; Kim JS; Kim JM; Lee JY; Jung HC; Song IS
Int J Cancer; 2008 Aug; 123(4):951-7. PubMed ID: 18521906
[TBL] [Abstract][Full Text] [Related]
11. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer.
Koh SJ; Kim JM; Kim IK; Ko SH; Kim JS
J Gastroenterol Hepatol; 2014 Mar; 29(3):502-10. PubMed ID: 24716225
[TBL] [Abstract][Full Text] [Related]
13. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
14. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
15. Novel Histone Deacetylase 6 Inhibitor CKD-506 Inhibits NF-κB Signaling in Intestinal Epithelial Cells and Macrophages and Ameliorates Acute and Chronic Murine Colitis.
Lee JW; Lee SM; Chun J; Im JP; Seo SK; Ha N; Il Choi Y; Kim JS
Inflamm Bowel Dis; 2020 May; 26(6):852-862. PubMed ID: 31895948
[TBL] [Abstract][Full Text] [Related]
16. Arvelexin inhibits colonic inflammation by suppression of NF-κB activation in dextran sulfate sodium-induced mice and TNF-α-induced colonic epithelial cells.
Cho EJ; Shin JS; Chung KS; Lee YS; Cho YW; Baek NI; Chung HG; Lee KT
J Agric Food Chem; 2012 Aug; 60(30):7398-407. PubMed ID: 22794033
[TBL] [Abstract][Full Text] [Related]
17. Astragalin Inhibits Nuclear Factor-κB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice.
Han YM; Koh J; Kim JH; Lee J; Im JP; Kim JS
Gut Liver; 2021 Jan; 15(1):100-108. PubMed ID: 32390406
[TBL] [Abstract][Full Text] [Related]
18. Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis.
Onizawa M; Nagaishi T; Kanai T; Nagano K; Oshima S; Nemoto Y; Yoshioka A; Totsuka T; Okamoto R; Nakamura T; Sakamoto N; Tsuchiya K; Aoki K; Ohya K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G850-9. PubMed ID: 19179628
[TBL] [Abstract][Full Text] [Related]
19. The guggulsterone derivative GG-52 inhibits NF-κB signaling in bone marrow-derived dendritic cells and attenuates colitis in IL-10 knockout mice.
Kang SJ; Kim JM; Koh SJ; Kim SH; Im JP; Jung HC; Kim JS
Life Sci; 2013 Jun; 92(22):1064-71. PubMed ID: 23603141
[TBL] [Abstract][Full Text] [Related]
20. Soluble Siglec-9 alleviates intestinal inflammation through inhibition of the NF-κB pathway.
Kang EA; Soh H; Park S; Lee HJ; Im JP; Kim JS
Int Immunopharmacol; 2020 Sep; 86():106695. PubMed ID: 32570035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
